Company / R&D per Share
Illumina, Inc. R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$6.08
FY2025
5-year range
$4.34 / $8.57
FY2021-FY2025
Trend
-17.3%
vs FY2024
Sector context
#4 of 108
Health Care
What the data says
Among 108 Health Care companies, Illumina, Inc. is in the top 4% for r&d per share. R&D per Share has fluctuated over the past 10 years, ranging from $2.75 in FY2017 to $8.57 in FY2023.
Based on SEC 10-K filings.
6.08 in FY2025 with a 5-year CAGR of +5.6%. Top quartile in the Health Care sector.
Declined from $8.57 to $6.08 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +11.9%
- 5-Year CAGR
- +5.6%
- 10-Year CAGR
- -
Sector benchmark
Top 4% in Health CareTop 4% of 108This company $6.08 Sector average $2.07
▼
+193.2% above sector average
Key checks
Key Insights
- In FY2025, r&d per share decreased 17.3% year-over-year.
- Ranks #4 out of 108 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2023.
- Lowest r&d per share in the period was in FY2017.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
- Strong return on equity: 29.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.08 | -17.3% |
| FY2024 | $7.35 | -14.2% |
| FY2023 | $8.57 | +97.3% |
| FY2022 | $4.34 | -46.5% |
| FY2021 | $8.12 | +74.9% |
| FY2020 | $4.64 | +24.9% |
| FY2019 | $3.71 | +8.3% |
| FY2018 | $3.43 | +24.8% |
| FY2017 | $2.75 | -20.1% |
| FY2016 | $3.44 | +23.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026